Aptevo Therapeutics Inc.

NasdaqCM:APVO Stock Report

Market Cap: US$4.9m

Aptevo Therapeutics Inc. Company Information

Aptevo Therapeutics Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Aptevo Therapeutics Inc.
  • Ticker: APVO
  • Exchange: NasdaqCM
  • Founded: 2016
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$4.939m
  • Shares Outstanding: 18.51m
  • Website: https://www.aptevotherapeutics.com

Number of Employees

Location

  • Aptevo Therapeutics Inc.
  • 2401 4th Avenue
  • Suite 1050
  • Seattle
  • Washington
  • 98121
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
APVONasdaqCM (Nasdaq Capital Market)YesCommon SharesUSUSDAug 2016
AP8DB (Deutsche Boerse AG)YesCommon SharesDEEURAug 2016

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/22 17:39
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.